Table 1.
AR | Coefficient, r | p value |
---|---|---|
Implantation-related genes | ||
Lif | −0.39 | 0.08 |
Nr2f2 | 0.31 | 0.17 |
Pc6 | 0.06 | 0.81 |
Ptch | 0.41 | 0.05 |
Spp1 | −0.46 | 0.04 |
Prl | 0.56 | 0.01 |
Igfbp1 | −0.54 | 0.02 |
Pgr | 0.38 | 0.08 |
Hoxa10 | −0.16 | 0.49 |
Hoxa11 | −0.25 | 0.28 |
Il11 | 0.10 | 0.66 |
Hbegf | 0.46 | 0.04 |
Uterine cell marker proteins | ||
pan-Cytokeratin | 0.03 | 0.88 |
Vimentin | 0.69 | < 0.01 |
α-SMA | 0.59 | < 0.01 |
n = 5–6/GD
AR androgen receptor, Lif leukemia inhibitory factor, Nr2f2 nuclear receptor subfamily 2 group F member 2, Pc6 protein convertase 5/6, Ptch patched, Spp1 osteopontin/secreted phosphoprotein 1, Prl prolactin, Igfbp1 insulin-like growth factor binding protein 1, Pgr progesterone receptor, Hoxa10 homeobox A10, Il11 interleukin-11, Hbegf heparin-binding EGF-like growth factor, α-SMA α-smooth muscle actin